sustained
发表于 2025-3-21 18:24:02
书目名称RAMPs影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0820053<br><br> <br><br>书目名称RAMPs影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0820053<br><br> <br><br>书目名称RAMPs网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0820053<br><br> <br><br>书目名称RAMPs网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0820053<br><br> <br><br>书目名称RAMPs被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0820053<br><br> <br><br>书目名称RAMPs被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0820053<br><br> <br><br>书目名称RAMPs年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0820053<br><br> <br><br>书目名称RAMPs年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0820053<br><br> <br><br>书目名称RAMPs读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0820053<br><br> <br><br>书目名称RAMPs读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0820053<br><br> <br><br>
GNAW
发表于 2025-3-21 23:11:42
William S. Spielman,Narayanan ParameswaranSource of basic studies that range from biochemistry to molecular biology to receptor pharmacology and physiology.Written by authors well known in the RAMPs field.Provides information for scientists a
Morbid
发表于 2025-3-22 02:06:59
978-1-4939-5292-2The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Science+Busines
Diuretic
发表于 2025-3-22 08:24:01
RAMPs978-1-4614-2364-5Series ISSN 0065-2598 Series E-ISSN 2214-8019
Ostrich
发表于 2025-3-22 10:02:30
http://reply.papertrans.cn/83/8201/820053/820053_5.png
幼稚
发表于 2025-3-22 14:28:40
http://reply.papertrans.cn/83/8201/820053/820053_6.png
IRATE
发表于 2025-3-22 19:52:35
https://doi.org/10.1007/978-1-4614-2364-5GPCRs; Narayanan Parameswaran; Protein; RAMPs; Receptor; William S;Spielman
Cholecystokinin
发表于 2025-3-22 23:36:31
http://reply.papertrans.cn/83/8201/820053/820053_8.png
PET-scan
发表于 2025-3-23 03:02:07
http://reply.papertrans.cn/83/8201/820053/820053_9.png
negotiable
发表于 2025-3-23 07:55:18
Regulation of RAMP Expression in Diseases, all three RAMP isoforms contributes to the cardioprotective effects of the CLR/RAMP ligands. On the other hand, strong evidence exists for the involvement of AM in various cancers and that its action is mediated by the upregulation of RAMP isoforms, RAMP-2 and -3. Though limited, a few studies have